STAT3 and hyper-IgE syndrome: As shown by studies in hyper-IgE syndrome (HIES) patients, the loss-of-function mutations of STAT3 abrogates the DC responsiveness to IL-10 and thereby impairs their tolerogenic functions and ability to stimulate differentiation of CD4+ T cells to regulatory T cells (Tregs) [36].